National and Kapodistrian University of Athens
Influence of lesion complexity and coating formulation on local coating penetration and downstream embolization after treatment with drug-coated balloons
Abstract
dc:descriptionBackground Drug-coated balloons (DCBs) are widely applied for the treatment of vascular stenoses, delivering an antiproliferative drug (e.g. paclitaxel) locally to inhibit neointimal proliferation. However, coating loss during tracking and inflation remains a largely underexplored factor that may compromise delivery efficacy and contribute to off-target drug exposure. This work aimed to evaluate the extent of premature drug loss and off-target delivery and its underlying mechanisms using an interdisciplinary experimental platform combining in vivo, in silico, and in vitro models. Methods A porcine model of in-stent restenosis (ISR) was created through plain balloon overstretch and stent implantation. DCBs were applied to ISR and naïve peripheral arteries, with systemic plasma, target, upstream, downstream, and systemic tissues collected for LC-MS/MS drug quantification. Angiographic and histological assessments were performed to evaluate lesion morphology and drug distribution. Complementary benchtop and computational simulations were conducted to dissect key interventional and mechanical contributors to coating loss and investigate friction- and attachment-dependent drug transfer. Results Systemic plasma sampling revealed peak paclitaxel concentrations post-tracking, indicating that approximately 44.5% of the nominal drug load is lost prior to inflation, while only 1.5% was detected post-inflation. No significant difference in drug delivery was observed between ISR and naïve arteries and their downstream tissue. Notably, upstream arterial tissue at vascular bends showed substantial paclitaxel concentrations (up to 46.5% of target site concentrations), suggesting frictional coating transfer during tracking. Benchtop friction experiments confirmed high drug transfer under low-pressure shear conditions, exceeding inflation-driven delivery. In vitro11models further demonstrated strong hydrophobic surface-mediated attachment of paclitaxel particles to phospholipid-rich matrices, offering an explanation for paclitaxel retention in systemic organs, particularly the lung. Conclusion This study reveals that significant paclitaxel loss occurs during DCB tracking, driven by vascular geometries and frictional mechanisms, resulting in unintended drug deposition in upstream vessels and systemic tissues. These off-target delivery routes can compromise therapeutic efficiency and safety. Improved device designs incorporating protective coatings or triggered-release systems, and early-timepoint pharmacokinetic evaluations, are critical to optimize DCB performance and minimize systemic exposure.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tscheuschner, Linnea
- Τσχέυσχνερ, Λίννεα
Subjects
dc:subject × 14- Μπαλόνια επικαλυμμένα με φάρμακο
- Περιφερική αρτηριακή νόσος
- Παράδοση εκτός στόχου
- Drug-coated balloons
- Peripheral arterial disease
- Off-target drug delivery
- Animal study
- In-vitro study
- In-silico study
- Βιοϊατρική Μηχανική
- Επιστήμες Μηχανικού και Τεχνολογία
- Medical Engineering
- Engineering and Technology
- Biomedical Engineering
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59229